Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 607363, 11 pages
http://dx.doi.org/10.1155/2015/607363
Review Article

Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis

1Immunology Department, National School of Biological Sciences, National Polytechnic Institute, Plan de Ayala y Prolongación de Carpio S/N, Colonia Santo Tomás, Miguel Hidalgo, 11340 Mexico City, DF, Mexico
2Microbiology Department, National School of Biological Sciences, National Polytechnic Institute, Plan de Ayala y Prolongación de Carpio S/N, Colonia Santo Tomás, Miguel Hidalgo, 11340 Mexico City, DF, Mexico

Received 13 March 2015; Accepted 21 May 2015

Academic Editor: Julio Galvez

Copyright © 2015 Azael Torales-Cardeña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Gelfand, R. S. Stern, T. Nijsten et al., “The prevalence of psoriasis in African Americans: results from a population-based study,” Journal of the American Academy of Dermatology, vol. 52, no. 1, pp. 23–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Icen, C. S. Crowson, M. T. McEvoy, F. J. Dann, S. E. Gabriel, and H. Maradit Kremers, “Trends in incidence of adult-onset psoriasis over three decades: a population-based study,” Journal of the American Academy of Dermatology, vol. 60, no. 3, pp. 394–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Choi and J. Y. M. Koo, “Quality of life issues in psoriasis,” Journal of the American Academy of Dermatology, vol. 49, no. 2, supplement, pp. S57–S61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Takahashi and H. Iizuka, “Psoriasis and metabolic syndrome,” Journal of Dermatology, vol. 39, no. 3, pp. 212–218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. Tsoi, S. L. Spain, J. Knight et al., “Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity,” Nature Genetics, vol. 44, no. 12, pp. 1341–1348, 2012. View at Publisher · View at Google Scholar
  6. S. Pantelyushin, S. Haak, B. Ingold et al., “Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice,” Journal of Clinical Investigation, vol. 122, no. 6, pp. 2252–2256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F. O. Nestle, D. H. Kaplan, and J. Barker, “Psoriasis,” The New England Journal of Medicine, vol. 361, no. 5, pp. 496–509, 2009. View at Publisher · View at Google Scholar
  8. P. W. Cook, J. R. Brown, K. A. Cornell, and M. R. Pittelkow, “Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis,” Experimental Dermatology, vol. 13, no. 6, pp. 347–356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. W. Cook, M. Piepkorn, C. H. Clegg et al., “Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype,” The Journal of Clinical Investigation, vol. 100, no. 9, pp. 2286–2294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Romanowska, L. Reilly, C. N. A. Palmer, M. C. U. Gustafsson, and J. Foerster, “Activation of PPARβ/δ causes a psoriasis-like skin disease in vivo,” PLoS ONE, vol. 5, no. 3, Article ID e9701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Romanowska, N. Al Yacoub, H. Seidel et al., “PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor,” Journal of Investigative Dermatology, vol. 128, no. 1, pp. 110–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Westergaard, J. Henningsen, C. Johansen et al., “Expression and localization of peroxisome proliferator-activated receptors and nuclear factor κB in normal and lesional psoriatic skin,” Journal of Investigative Dermatology, vol. 121, no. 5, pp. 1104–1117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. S. Tan, L. Michalik, N. Noy et al., “Critical roles of PPARbeta/delta in keratinocyte response to inflammation,” Genes and Development, vol. 15, no. 24, pp. 3263–3277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Di-Poï, L. Michalik, N. S. Tan, B. Desvergne, and W. Wahli, “The anti-apoptotic role of PPARβ contributes to efficient skin wound healing,” Journal of Steroid Biochemistry and Molecular Biology, vol. 85, no. 2–5, pp. 257–265, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Icre, W. Wahli, and L. Michalik, “Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis,” Journal of Investigative Dermatology Symposium Proceedings, vol. 11, no. 1, pp. 30–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pasparakis, G. Courtois, M. Hafner et al., “TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2,” Nature, vol. 417, no. 6891, pp. 861–866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Lind, B. Rozell, R. P. A. Wallin et al., “Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4972–4977, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Grinberg-Bleyer, T. Dainichi, H. Oh et al., “Cutting edge: NF-κB p65 and c-Rel control epidermal development and immune homeostasis in the skin,” The Journal of Immunology, vol. 194, no. 6, pp. 2472–2476, 2015. View at Publisher · View at Google Scholar
  19. R. Zenz, R. Eferl, L. Kenner et al., “Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins,” Nature, vol. 437, no. 7057, pp. 369–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Uto-Konomi, K. Miyauchi, N. Ozaki et al., “Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines,” PLoS ONE, vol. 7, no. 7, Article ID e40343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sano, K. S. Chan, S. Carbajal et al., “Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model,” Nature Medicine, vol. 11, no. 1, pp. 43–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Hida, K. Ogasawara, K. Sato et al., “CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling,” Immunity, vol. 13, no. 5, pp. 643–655, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. F. O. Nestle, C. Conrad, A. Tun-Kyi et al., “Plasmacytoid predendritic cells initiate psoriasis through interferon-α production,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Blumberg, H. Dinh, E. S. Trueblood et al., “Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2603–2614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. E. Towne and J. E. Sims, “IL-36 in psoriasis,” Current Opinion in Pharmacology, vol. 12, no. 4, pp. 486–490, 2012. View at Google Scholar
  26. L. van der Fits, S. Mourits, J. S. A. Voerman et al., “Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis,” The Journal of Immunology, vol. 182, no. 9, pp. 5836–5845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Bullard, K. Scharfetter-Kochanek, M. J. Mcarthur et al., “A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 5, pp. 2116–2121, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Singh, M. Gatzka, T. Peters et al., “Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis,” Journal of Immunology, vol. 190, no. 6, pp. 2544–2553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-P. Xia, B. Li, D. Hylton, M. Detmar, G. D. Yancopoulos, and J. S. Rudge, “Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis,” Blood, vol. 102, no. 1, pp. 161–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Wolfram, D. Diaconu, D. A. Hatala et al., “Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis,” American Journal of Pathology, vol. 174, no. 4, pp. 1443–1458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. G. Li, D. Wang, X.-H. Feng, and X.-J. Wang, “Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder,” The EMBO Journal, vol. 23, no. 8, pp. 1770–1781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. J. Freedman, Z.-Y. J. Sun, F. Poy et al., “Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 8, pp. 5367–5372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Srinivas, L.-P. Zhang, X.-H. Zhu, and J. Caro, “Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor α (HIF-α) proteins,” Biochemical and Biophysical Research Communications, vol. 260, no. 2, pp. 557–561, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Palazon, A. Goldrath, V. Nizet, and R. Johnson, “HIF transcription factors, inflammation, and immunity,” Immunity, vol. 41, no. 4, pp. 518–528, 2014. View at Publisher · View at Google Scholar
  35. S. C. Cheng, J. Quintin, R. A. Cramer et al., “mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity,” Science, vol. 345, no. 6204, Article ID 1250684, 2014. View at Publisher · View at Google Scholar
  36. R. J. Appelhoffl, Y.-M. Tian, R. R. Raval et al., “Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor,” Journal of Biological Chemistry, vol. 279, no. 37, pp. 38458–38465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Berra, E. Benizri, A. Ginouvès, V. Volmat, D. Roux, and J. Pouysségur, “HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia,” The EMBO Journal, vol. 22, no. 16, pp. 4082–4090, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. W.-C. Hon, M. I. Wilson, K. Harlos et al., “Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL,” Nature, vol. 417, no. 6892, pp. 975–978, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J. H. Min, H. Yang, M. Ivan, F. Gertler, W. G. Kaelin Jr., and N. P. Pavietich, “Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling,” Science, vol. 296, no. 5574, pp. 1886–1889, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. H. B. Jin, Y. V. Liu, K. R. McDonald et al., “Spermidine/Spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α,” The Journal of Biological Chemistry, vol. 282, no. 32, pp. 23572–23580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-W. Jeong, M.-K. Bae, M.-Y. Ahn et al., “Regulation and destabilization of HIF-1α by ARD1-mediated acetylation,” Cell, vol. 111, no. 5, pp. 709–720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-G. Yoo, G. Kong, and M.-O. Lee, “Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1,” EMBO Journal, vol. 25, no. 6, pp. 1231–1241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Li, D. Wang, X. Na, S. R. Schoen, E. M. Messing, and G. Wu, “Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor,” Biochemical and Biophysical Research Communications, vol. 294, no. 3, pp. 700–709, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Li, D. Wang, E. M. Messing, and G. Wu, “VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha,” EMBO Reports, vol. 6, no. 4, pp. 373–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. V. Liu, J. H. Baek, H. Zhang, R. Diez, R. N. Cole, and G. L. Semenza, “RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α,” Molecular Cell, vol. 25, no. 2, pp. 207–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. V. Liu and G. L. Semenza, “RACK1 vs. HSP90: competition for HIF-1α degradation vs. stabilization,” Cell Cycle, vol. 6, no. 6, pp. 656–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Amir, R. Wang, J. W. Simons, and N. J. Mabjeesh, “SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation,” Journal of Biological Chemistry, vol. 284, no. 17, pp. 11142–11151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-K. Bae, M.-Y. Ahn, J.-W. Jeong et al., “Jab1 interacts directly with HIF-1α and regulates its stability,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 9–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-N. Li, M.-M. Xi, Y. Guo, C.-X. Hai, W.-L. Yang, and X.-J. Qin, “NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1alpha stabilization by inhibiting prolyl hydroxylases activity,” Toxicology Letters, vol. 224, no. 2, pp. 165–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Acker, J. Fandrey, and H. Acker, “The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases,” Cardiovascular Research, vol. 71, no. 2, pp. 195–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. S. Kim, H. J. Kwon, Y. M. Lee et al., “Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes,” Nature Medicine, vol. 7, no. 4, pp. 437–443, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Reynoso-Roldán, M. L. Roldán, J. C. Cancino-Diaz, S. Rodríguez-Martínez, and M. E. Cancino-Diaz, “Vascular endothelial growth factor production is induced by histone deacetylase 1 and suppressed by von Hippel-Lindau protein in HaCaT cells,” Clinical and Investigative Medicine, vol. 35, no. 6, pp. E340–E350, 2012. View at Google Scholar · View at Scopus
  53. H. Kato, S. Tamamizu-Kato, and F. Shibasaki, “Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity,” The Journal of Biological Chemistry, vol. 279, no. 40, pp. 41966–41974, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Carrero, K. Okamoto, P. Coumailleau, S. A. O'Brien, H. Tanaka, and L. Poellinger, “Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α,” Molecular and Cellular Biology, vol. 20, no. 1, pp. 402–415, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Ema, K. Hirota, J. Mimura et al., “Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300,” The EMBO Journal, vol. 18, no. 7, pp. 1905–1914, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Lando, D. J. Peet, J. J. Gorman, D. A. Whelan, M. L. Whitelaw, and R. K. Bruick, “FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor,” Genes and Development, vol. 16, no. 12, pp. 1466–1471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. H.-E. Moon, M.-Y. Ahn, J. A. Park, K.-J. Min, Y.-W. Kwon, and K.-W. Kim, “Negative regulation of hypoxia inducible factor-1α by necdin,” FEBS Letters, vol. 579, no. 17, pp. 3797–3801, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Hägele, B. Behnam, E. Borter et al., “TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha,” FEBS Letters, vol. 580, no. 15, pp. 3731–3738, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. P. A. J. Muller, B. V. de Sluis, A. J. Groot et al., “Nuclear-cytosolic transport of COMMD1 regulates NF-κB and HIF-1 activity,” Traffic, vol. 10, no. 5, pp. 514–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Fatyol and A. A. Szalay, “The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription,” The Journal of Biological Chemistry, vol. 276, no. 30, pp. 28421–28429, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Laemmle, A. Lechleiter, V. Roh et al., “Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions,” PLoS ONE, vol. 7, no. 3, Article ID e33433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. S. H. Lee, Y. J. Lee, and H. J. Han, “Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: involvement of PI3K/Akt and FAK,” Journal of Cellular Physiology, vol. 226, no. 2, pp. 484–493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. K. D. Cowden Dahl, S. E. Robertson, V. M. Weaver, and M. C. Simon, “Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression,” Molecular Biology of the Cell, vol. 16, no. 4, pp. 1901–1912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. M. H. Ryu, H. M. Park, J. Chung, C. H. Lee, and H. R. Park, “Hypoxia-inducible factor-1α mediates oral squamous cell carcinoma invasion via upregulation of α5 integrin and fibronectin,” Biochemical and Biophysical Research Communications, vol. 393, no. 1, pp. 11–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Krishnamachary, D. Zagzag, H. Nagasawa et al., “Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B,” Cancer Research, vol. 66, no. 5, pp. 2725–2731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. E. A. O'Toole, R. Van Koningsveld, M. Chen, and D. T. Woodley, “Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 47–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. S.-W. Jing, Y.-D. Wang, M. Kuroda et al., “HIF-1α contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression,” Acta Medica Okayama, vol. 66, no. 5, pp. 399–407, 2012. View at Google Scholar · View at Scopus
  68. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, and P. M. Comoglio, “Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene,” Cancer Cell, vol. 3, no. 4, pp. 347–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Ishikawa, K.-I. Nakashiro, S. K. Klosek et al., “Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma,” Oncology Reports, vol. 21, no. 3, pp. 707–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Li, X. Qiu, S. Zhang, Q. Zhang, and E. Wang, “Hypoxia induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells,” Cancer Biology and Therapy, vol. 8, no. 4, pp. 322–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Chen, L. Zhang, Y. Pan, X. Ren, and Q. Hao, “Over-expression of semaphorin4d, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 13264–13274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. L. L. Nikitenko, D. M. Smith, R. Bicknell, and M. C. P. Rees, “Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia,” The FASEB Journal, vol. 17, no. 11, pp. 1499–1501, 2003. View at Google Scholar · View at Scopus
  73. R. K. Bruick, “Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9082–9087, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. G. L. Wang and G. L. Semenza, “Molecular basis of hypoxia-induced erythropoietin expression,” Current Opinion in Hematology, vol. 3, no. 2, pp. 156–162, 1996. View at Publisher · View at Google Scholar
  75. M. Hayashi, M. Sakata, T. Takeda et al., “Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells,” Journal of Endocrinology, vol. 183, no. 1, pp. 145–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Liu, Y.-M. Li, R.-F. Tian et al., “The expression and significance of HIF-1α and GLUT-3 in glioma,” Brain Research, vol. 1304, pp. 149–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Obach, À. Navarro-Sabaté, J. Caro et al., “6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia,” Journal of Biological Chemistry, vol. 279, no. 51, pp. 53562–53570, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Z. Shi, R. Wang, G. Huang et al., “HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells,” Journal of Experimental Medicine, vol. 208, no. 7, pp. 1367–1376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. E. V. Dang, J. Barbi, H.-Y. Yang et al., “Control of TH17/Treg balance by hypoxia-inducible factor 1,” Cell, vol. 146, no. 5, pp. 772–784, 2011. View at Publisher · View at Google Scholar
  80. A. P. Levy, N. S. Levy, S. Wegner, and M. A. Goldberg, “Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia,” The Journal of Biological Chemistry, vol. 270, no. 22, pp. 13333–13340, 1995. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Liu, S. R. Cox, T. Morita, and S. Kourembanas, “Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5 enhancer,” Circulation Research, vol. 77, no. 3, pp. 638–643, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. J. A. Forsythe, B.-H. Jiang, N. V. Iyer et al., “Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 4604–4613, 1996. View at Google Scholar · View at Scopus
  83. N. Takeda, K. Maemura, Y. Imai et al., “Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1,” Circulation Research, vol. 95, no. 2, pp. 146–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Elvert, A. Kappel, R. Heidenreich et al., “Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1),” The Journal of Biological Chemistry, vol. 278, no. 9, pp. 7520–7530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. Y.-T. Ahn, M.-S. Chua, J. P. Whitlock Jr. et al., “Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells,” International Journal of Oncology, vol. 37, no. 6, pp. 1627–1638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Abdulmalek, F. Ashur, N. Ezer, Y. Fengchun, S. Magder, and S. N. A. Hussain, “Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 281, no. 3, pp. L582–L590, 2001. View at Google Scholar · View at Scopus
  87. M. M. Hickey and M. C. Simon, “Regulation of angiogenesis by hypoxia and hypoxia-inducible factors,” Current Topics in Developmental Biology, vol. 76, pp. 217–257, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. Z.-B. Han, H. Ren, H. Zhao et al., “Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF),” Carcinogenesis, vol. 29, no. 10, pp. 1853–1861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Rosenberger, C. Solovan, A. D. Rosenberger et al., “Upregulation of hypoxia-inducible factors in normal and psoriatic skin,” Journal of Investigative Dermatology, vol. 127, no. 10, pp. 2445–2452, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. L. E. Tovar-Castillo, J. C. Cancino-Díaz, F. García-Vázquez et al., “Under-expression of VHL and over-expression of HDAC-1, HIF-1α, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis,” International Journal of Dermatology, vol. 46, no. 3, pp. 239–246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Creamer, D. Sullivan, R. Bicknell, and J. Barker, “Angiogenesis in psoriasis,” Angiogenesis, vol. 5, no. 4, pp. 231–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Heidenreich, M. Röcken, and K. Ghoreschi, “Angiogenesis drives psoriasis pathogenesis,” International Journal of Experimental Pathology, vol. 90, no. 3, pp. 232–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. D. D. Balci, N. Duran, B. Ozer, R. Gunesacar, Y. Onlen, and J. Z. Yenin, “High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis,” European Journal of Dermatology, vol. 19, no. 3, pp. 238–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. V. Ruíz-González, J. C. Cancino-Diaz, S. Rodríguez-Martínez, and M. E. Cancino-diaz, “Keratinocytes treated with peptidoglycan from Staphylococcus aureus produce vascular endothelial growth factor, and its expression is amplified by the subsequent production of interleukin-13,” International Journal of Dermatology, vol. 48, no. 8, pp. 846–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Rodríguez-Martínez, J. C. Cancino-Diaz, L. M. Vargas-Zuñiga, and M. E. Cancino-Diaz, “LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes,” International Journal of Dermatology, vol. 47, no. 5, pp. 457–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. C. I. Chamorro, G. Weber, A. Grönberg, A. Pivarcsi, and M. Ståhle, “The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes,” Journal of Investigative Dermatology, vol. 129, no. 4, pp. 937–944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. E. A. Vázquez-Sánchez, M. Rodríguez-Romero, L. E. Sánchez-Torres et al., “Peptidoglycan from Staphylococcus aureus has an anti-apoptotic effect in HaCaT keratinocytes mediated by the production of the cellular inhibitor of apoptosis protein-2,” Microbiology and Immunology, vol. 58, no. 2, pp. 87–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. E. Fitch, E. Harper, I. Skorcheva, S. E. Kurtz, and A. Blauvelt, “Pathophysiology of psoriasis: recent advances on IL-23 and TH17 cytokines,” Current Rheumatology Reports, vol. 9, no. 6, pp. 461–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Starnes, M. J. Robertson, G. Sledge et al., “Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production,” The Journal of Immunology, vol. 167, no. 8, pp. 4137–4140, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Ghoreschi, C. Weigert, and M. Röcken, “Immunopathogenesis and role of T cells in psoriasis,” Clinics in Dermatology, vol. 25, no. 6, pp. 574–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. L. C. Zaba, J. Fuentes-Duculan, N. J. Eungdamrong et al., “Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells,” Journal of Investigative Dermatology, vol. 129, no. 1, pp. 79–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Kuroda, A. Sapadin, T. Shoji, R. Fleischmajer, and M. Lebwohl, “Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis,” Journal of Investigative Dermatology, vol. 116, no. 5, pp. 713–720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. T. N. Sato, Y. Tozawa, U. Deutsch et al., “Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation,” Nature, vol. 376, no. 6535, pp. 70–74, 1995. View at Publisher · View at Google Scholar · View at Scopus
  104. D. Voskas, N. Jones, P. van Slyke et al., “A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice,” The American Journal of Pathology, vol. 166, no. 3, pp. 843–855, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. T. R. Mosmann, H. Cherwinski, and M. W. Bond, “Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins,” Journal of Immunology, vol. 136, no. 7, pp. 2348–2357, 1986. View at Google Scholar · View at Scopus
  106. W. Lew, A. M. Bowcock, and J. G. Krueger, “Psoriasis vulgaris: Cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression,” Trends in Immunology, vol. 25, no. 6, pp. 295–305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. Z. Jadali, M. Izad, M. B. Eslami et al., “Th1/Th2 cytokines in psoriasis,” Iranian Journal of Public Health, vol. 36, no. 2, pp. 87–91, 2007. View at Google Scholar · View at Scopus
  108. L. Steinman, “A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. Iwakura and H. Ishigame, “The IL-23/IL-17 axis in inflammation,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1218–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Fossiez, O. Djossou, P. Chomarat et al., “T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines,” The Journal of Experimental Medicine, vol. 183, no. 6, pp. 2593–2603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  113. M. B. M. Teunissen, C. W. Koomen, R. de Waal Malefyt, E. A. Wierenga, and J. D. Bos, “Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes,” Journal of Investigative Dermatology, vol. 111, no. 4, pp. 645–649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. O. Arican, M. Aral, S. Sasmaz, and P. Ciragil, “Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity,” Mediators of Inflammation, vol. 2005, no. 5, pp. 273–279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. S. Kagami, H. L. Rizzo, J. J. Lee, Y. Koguchi, and A. Blauvelt, “Circulating Th17, Th22, and Th1 cells are increased in psoriasis,” Journal of Investigative Dermatology, vol. 130, no. 5, pp. 1373–1383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. J. R. Chan, W. Blumenschein, E. Murphy et al., “IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2577–2587, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. L. Zhang, X.-Q. Yang, J. Cheng, R.-S. Hui, and T.-W. Gao, “Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity,” Clinical Immunology, vol. 135, no. 1, pp. 108–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. M. J. McGeachy and D. J. Cua, “Th17 cell differentiation: the long and winding road,” Immunity, vol. 28, no. 4, pp. 445–453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. L. Zhou, I. I. Ivanov, R. Spolski et al., “IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. X. O. Yang, R. Nurieva, G. J. Martinez et al., “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs,” Immunity, vol. 29, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Laurence, C. M. Tato, T. S. Davidson et al., “Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation,” Immunity, vol. 26, no. 3, pp. 371–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. X.-P. Yang, K. Ghoreschi, S. M. Steward-Tharp et al., “Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5,” Nature Immunology, vol. 12, no. 3, pp. 247–254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. L. M. Heltemes-Harris and M. A. Farrar, “The role of STAT5 in lymphocyte development and transformation,” Current Opinion in Immunology, vol. 24, no. 2, pp. 146–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. D. C. Newcomb, W. Zhou, M. L. Moore et al., “A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production,” The Journal of Immunology, vol. 182, no. 9, pp. 5317–5321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. D. C. Newcomb, M. G. Boswell, M. M. Huckabee et al., “IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner,” Journal of Immunology, vol. 188, no. 3, pp. 1027–1035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. J. C. Cancino-Díaz, E. Reyes-Maldonado, C. A. Bañuelos-Pánuco et al., “Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein,” Journal of Investigative Dermatology, vol. 119, no. 5, pp. 1114–1120, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. H. J. Bovenschen, P. C. van de Kerkhof, P. E. van Erp, R. Woestenenk, I. Joosten, and H. J. P. M. Koenen, “Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin,” Journal of Investigative Dermatology, vol. 131, no. 9, pp. 1853–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. Kim, B. H. Kim, H. Lee et al., “Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1alpha and NF-kappaB pathways,” Free Radical Biology and Medicine, vol. 51, no. 11, pp. 1985–1995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. E.-J. Yang, J. Lee, S.-Y. Lee et al., “EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1α with Th17/Treg control,” PLoS ONE, vol. 9, no. 2, Article ID e86062, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Wang, H. Flach, M. Onizawa, L. Wei, M. T. Mcmanus, and A. Weiss, “Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210,” Nature Immunology, vol. 15, no. 4, pp. 393–401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. K. Miyoshi, M. Takaishi, K. Nakajima et al., “Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 Inhibitor,” Journal of Investigative Dermatology, vol. 131, no. 1, pp. 108–117, 2011. View at Publisher · View at Google Scholar · View at Scopus